292 related articles for article (PubMed ID: 27861848)
1. Gamma-glutamyltransferase and risk of prostate cancer: Findings from the KIHD prospective cohort study.
Kunutsor SK; Laukkanen JA
Int J Cancer; 2017 Feb; 140(4):818-824. PubMed ID: 27861848
[TBL] [Abstract][Full Text] [Related]
2. γ-Glutamyltransferase and Risk of Sudden Cardiac Death in Middle-Aged Finnish Men: A New Prospective Cohort Study.
Kunutsor SK; Khan H; Laukkanen JA
J Am Heart Assoc; 2016 Feb; 5(2):. PubMed ID: 26857068
[TBL] [Abstract][Full Text] [Related]
3. Gamma glutamyltransferase and risk of future dementia in middle-aged to older Finnish men: A new prospective cohort study.
Kunutsor SK; Laukkanen JA
Alzheimers Dement; 2016 Sep; 12(9):931-941. PubMed ID: 27103259
[TBL] [Abstract][Full Text] [Related]
4. Baseline and long-term gamma-glutamyltransferase, heart failure and cardiac arrhythmias in middle-aged Finnish men: Prospective study and pooled analysis of published evidence.
Kunutsor SK; Laukkanen JA; Bluemke DA; Butler J; Khan H
Eur J Prev Cardiol; 2016 Sep; 23(13):1354-62. PubMed ID: 27084895
[TBL] [Abstract][Full Text] [Related]
5. Gamma-Glutamyltransferase and Future Risk of Pneumonia: A Long-Term Prospective Cohort Study.
Kunutsor SK; Laukkanen JA
Lung; 2017 Dec; 195(6):799-803. PubMed ID: 28993933
[TBL] [Abstract][Full Text] [Related]
6. Gamma-glutamyltransferase and risk of chronic kidney disease: A prospective cohort study.
Kunutsor SK; Laukkanen JA
Clin Chim Acta; 2017 Oct; 473():39-44. PubMed ID: 28811239
[TBL] [Abstract][Full Text] [Related]
7. Joint effects of coffee consumption and serum gamma-glutamyltransferase on the risk of liver cancer.
Hu G; Tuomilehto J; Pukkala E; Hakulinen T; Antikainen R; Vartiainen E; Jousilahti P
Hepatology; 2008 Jul; 48(1):129-36. PubMed ID: 18537182
[TBL] [Abstract][Full Text] [Related]
8. Association between serum γ-glutamyltransferase and chronic kidney disease in urban Han Chinese: a prospective cohort study.
Shen ZW; Xing J; Wang QL; Faheem A; Ji X; Li J; Bian WW; Jiang Z; Li XJ; Xue FZ; Liu J
Int Urol Nephrol; 2017 Feb; 49(2):303-312. PubMed ID: 27704320
[TBL] [Abstract][Full Text] [Related]
9. γ-Glutamyltransferase and cancer risk: The Korean cancer prevention study.
Mok Y; Son DK; Yun YD; Jee SH; Samet JM
Int J Cancer; 2016 Jan; 138(2):311-9. PubMed ID: 26111622
[TBL] [Abstract][Full Text] [Related]
10. Longitudinal increase in gamma-glutamyltransferase within the reference interval predicts metabolic syndrome in middle-aged Korean men.
Ryu S; Chang Y; Woo HY; Yoo SH; Choi NK; Lee WY; Kim I; Song J
Metabolism; 2010 May; 59(5):683-9. PubMed ID: 19922966
[TBL] [Abstract][Full Text] [Related]
11. Serum β-carotene in relation to risk of prostate cancer: the Kuopio Ischaemic Heart Disease Risk Factor study.
Karppi J; Kurl S; Laukkanen JA; Kauhanen J
Nutr Cancer; 2012 Apr; 64(3):361-7. PubMed ID: 22420939
[TBL] [Abstract][Full Text] [Related]
12. Glucose, lipids and gamma-glutamyl transferase measured before prostate cancer diagnosis and secondly diagnosed primary tumours: a prospective study in the Swedish AMORIS cohort.
Bosco C; Garmo H; Hammar N; Walldius G; Jungner I; Malmström H; Holmberg L; Van Hemelrijck M
BMC Cancer; 2018 Feb; 18(1):205. PubMed ID: 29463235
[TBL] [Abstract][Full Text] [Related]
13. Serum γ-glutamyltransferase: independent predictor of risk of diabetes, hypertension, metabolic syndrome, and coronary disease.
Onat A; Can G; Örnek E; Çiçek G; Ayhan E; Doğan Y
Obesity (Silver Spring); 2012 Apr; 20(4):842-8. PubMed ID: 21633402
[TBL] [Abstract][Full Text] [Related]
14. Prospective study of the association of gamma-glutamyltransferase with cancer incidence in women.
Strasak AM; Pfeiffer RM; Klenk J; Hilbe W; Oberaigner W; Gregory M; Concin H; Diem G; Pfeiffer KP; Ruttmann E; Ulmer H;
Int J Cancer; 2008 Oct; 123(8):1902-6. PubMed ID: 18688855
[TBL] [Abstract][Full Text] [Related]
15. Serum γ-glutamyltransferase and the risk of heart failure in men and women in Finland.
Wang Y; Tuomilehto J; Jousilahti P; Salomaa V; Li B; Antikainen R; Mähönen M; Katzmarzyk PT; Hu G
Heart; 2013 Feb; 99(3):163-7. PubMed ID: 23144292
[TBL] [Abstract][Full Text] [Related]
16. Prospective study of serum gamma-glutamyltransferase and risk of NIDDM.
Perry IJ; Wannamethee SG; Shaper AG
Diabetes Care; 1998 May; 21(5):732-7. PubMed ID: 9589232
[TBL] [Abstract][Full Text] [Related]
17. Circulating gamma glutamyltransferase and prediction of cardiovascular disease.
Kunutsor SK; Bakker SJ; Kootstra-Ros JE; Gansevoort RT; Dullaart RP
Atherosclerosis; 2015 Feb; 238(2):356-64. PubMed ID: 25555268
[TBL] [Abstract][Full Text] [Related]
18. Association between γ-glutamyltransferase level and incidence of atrial fibrillation: A nationwide population-based study.
Lee SR; Choi EK; Han KD; Cha MJ; Oh S
Int J Cardiol; 2017 Oct; 245():149-155. PubMed ID: 28757090
[TBL] [Abstract][Full Text] [Related]
19. Serum gamma-glutamyltransferase is a predictor of incident coronary events in apparently healthy men from the general population.
Meisinger C; Döring A; Schneider A; Löwel H;
Atherosclerosis; 2006 Dec; 189(2):297-302. PubMed ID: 16483579
[TBL] [Abstract][Full Text] [Related]
20. Intake of flavonoids and risk of cancer in Finnish men: The Kuopio Ischaemic Heart Disease Risk Factor Study.
Mursu J; Nurmi T; Tuomainen TP; Salonen JT; Pukkala E; Voutilainen S
Int J Cancer; 2008 Aug; 123(3):660-3. PubMed ID: 18338754
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
